Position
Essential Partners LLC in Maxcyte, Inc.
Back to the book · All holders of MXCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.48K$1.55 → $0.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q2 2025 | 167 | $364 | — | — | — | 0.0% |
| Q3 2025 | 2.42K | $3.83K | $1.58 | −$100 | $3.57K | 0.0% |
| Q4 2025 | 1.75K | $2.71K | $1.55 | −$53 | −$1.07K | 0.0% |
| Q1 2026 | 3.33K | $2.34K | $0.70 | −$1.48K | $1.11K | 0.0% |